Trends in the Prevalence of Tuberous Sclerosis Complex Manifestations: An Epidemiological Study of 166 Japanese Patients

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wataya Kaneda, Mari ^a   Tanaka, Mari ^a   Hamasaki, Toshimitsu ^a   Katayama, Ichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANGIOMYOLIPOMA; ARTICLE; AUTISM; CHILD; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; EPILEPSY; FASCIAL HEMANGIOFIBROMA; FEMALE; GENE; HEART RHABDOMYOMA; HEMANGIOFIBROMA; HUMAN; HYPOMELANOTIC MACULE; INFANT; INTELLECTUAL IMPAIRMENT; JAPANESE; KIDNEY CARCINOMA; KIDNEY CYST; LYMPHANGIOLEIOMYOMATOSIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; OVARY CYST; PERIVASCULAR EPITHELIOID CELL TUMOR; PRESCHOOL CHILD; PREVALENCE; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; RENAL ANGIOMYOLIPOMA; RHABDOMYOMA; SCHOOL CHILD; SHAGREEN PATCH; SKIN DISEASE; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; SYMPTOM; THYROID DISEASE; TREND STUDY; TSC1 GENE; TSC2 GENE; TUBEROUS SCLEROSIS; UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR; AGE; CHI SQUARE DISTRIBUTION; INTELLECTUAL DISABILITY; JAPAN; KIDNEY NEOPLASMS; PATHOLOGY; SKIN NEOPLASMS; UTERUS;

ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; EPILEPSY; FEMALE; HUMANS; INTELLECTUAL DISABILITY; JAPAN; KIDNEY NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MALE; PREVALENCE; SKIN NEOPLASMS; TUBEROUS SCLEROSIS; UTERUS;

EID: 84877870856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063910     Document Type: Article

References (66)

1. Osborne JP, Jones AC, Burley MW, Jeganathan D, Young J, et al. (2000) Non-penetrance in tuberous sclerosis. Lancet 355: 1698.
2. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, et al. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805-808.
3. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305-1315.
4. Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA, (2010) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51: 1236-1241.
5. Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, et al. (1999) Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 64: 1305-1315.
6. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, et al. (2006) Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int 70: 1777-1782.
7. Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, et al. (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68: 64-80.
8. Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, et al. (2007) Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 9: 88-100.
9. Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, et al. (2005) Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 13: 731-741.
10. Chopra M, Lawson JA, Wilson M, Kennedy SE, Taylor P, et al. (2011) An Australian tuberous sclerosis cohort: are surveillance guidelines being met? J Paediatr Child Health 47: 711-716.
11. Hong CH, Darling TN, Lee CH, (2009) Prevalence of tuberous sclerosis complex in Taiwan: a national population-based study. Neuroepidemiology 33: 335-341.
12. Yates JR, Maclean C, Higgins JN, Humphrey A, le Marechal K, et al. (2011) The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child.
13. Staley BA, Vail EA, Thiele EA, (2011) Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs. Pediatrics 127: e117-125.
14. Hallett L, Foster T, Liu Z, Blieden M, Valentim J, (2011) Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 27: 1571-1583.
15. Roach ES, Gomez MR, Northrup H, (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13: 624-628.
16. Sasongko TH, Wataya-Kaneda M, Koterazawa K, Gunadi, Yusoff S, et al. (2008) Novel mutations in 21 patients with tuberous sclerosis complex and variation of tandem splice-acceptor sites in TSC1 exon 14. Kobe J Med Sci 54: E73-81.
17. Curatolo P, Bombardieri R, Jozwiak S, (2008) Tuberous sclerosis. Lancet 372: 657-668.
18. Thiele EA, (2004) Managing epilepsy in tuberous sclerosis complex. J Child Neurol 19: 680-686.
19. Jozwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J, (2000) Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 15: 652-659.
20. Devlin LA, Shepherd CH, Crawford H, Morrison PJ, (2006) Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland. Dev Med Child Neurol 48: 495-499.
21. Holmes GL, Stafstrom CE, (2007) Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia 48: 617-630.
22. Franz DN, Bissler JJ, McCormack FX, (2010) Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics 41: 199-208.
23. Cass H, Sekaran D, Baird G, (2006) Medical investigation of children with autistic spectrum disorders. Child Care Health Dev 32: 521-533.
24. de Vries PJ, Hunt A, Bolton PF, (2007) The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry 16: 16-24.
25. Hunt A, Shepherd C, (1993) A prevalence study of autism in tuberous sclerosis. J Autism Dev Disord 23: 323-339.
26. Smalley SL, Tanguay PE, Smith M, Gutierrez G, (1992) Autism and tuberous sclerosis. J Autism Dev Disord 22: 339-355.
27. Webb DW, Fryer AE, Osborne JP, (1991) On the incidence of fits and mental retardation in tuberous sclerosis. J Med Genet 28: 395-397.
28. Jozwiak S, Kotulska K, Domanska-Pakiela D, Lojszczyk B, Syczewska M, et al. (2011) Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol 15: 424-431.
29. Jozwiak S, Goodman M, Lamm SH, (1998) Poor mental development in patients with tuberous sclerosis complex: clinical risk factors. Arch Neurol 55: 379-384.
30. Shepherd CW, Stephenson JB, (1992) Seizures and intellectual disability associated with tuberous sclerosis complex in the west of Scotland. Dev Med Child Neurol 34: 766-774.
31. Chou PC, Chang YJ, (2004) Prognostic factors for mental retardation in patients with tuberous sclerosis complex. Acta Neurol Taiwan 13: 10-13.
32. Joinson C, O'Callaghan FJ, Osborne JP, Martyn C, Harris T, et al. (2003) Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 33: 335-344.
33. Jansen FE, Vincken KL, Algra A, Anbeek P, Braams O, et al. (2008) Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology 70: 916-923.
34. Baskin HJ Jr, (2008) The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol 38: 936-952.
35. Castagnetti M, Vezzu B, Laverda A, Zampieri S, Rigamonti W, (2007) Urological counseling and followup in pediatric tuberous sclerosis complex. J Urol 178: 2155-2159.
36. Bernstein J, Robbins TO, (1991) Renal involvement in tuberous sclerosis. Ann N Y Acad Sci 615: 36-49.
37. Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES, (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160: 141-145.
38. Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, et al. (2002) Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 225: 78-82.
39. Hancock E, Osborne J, (2002) Lymphangioleiomyomatosis: a review of the literature. Respir Med 96: 1-6.
40. Castro M, Shepherd CW, Gomez MR, Lie JT, Ryu JH, (1995) Pulmonary tuberous sclerosis. Chest 107: 189-195.
41. Osborne JP, Fryer A, Webb D, (1991) Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 615: 125-127.
42. Adriaensen ME, Schaefer-Prokop CM, Duyndam DA, Zonnenberg BA, Prokop M, (2011) Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex. Clin Radiol 66: 625-628.
43. Urban T, Lazor R, Lacronique J, Murris M, Labrune S, et al. (1999) Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 78: 321-337.
44. Sogut A, Ozmen M, Sencer S, Caliskan M, Aydinli N, et al. (2002) Clinical features of tuberous sclerosis cases. Turk J Pediatr 44: 98-101.
45. Jozwiak J, Galus R, (2008) Molecular implications of skin lesions in tuberous sclerosis. Am J Dermatopathol 30: 256-261.
46. Jozwiak S, Schwartz RA, Janniger CK, Michalowicz R, Chmielik J, (1998) Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol 37: 911-917.
47. Hake S, (2011) Cutaneous manifestations of tuberous sclerosis. Ochsner J 10: 200-204.
48. Webb DW, Clarke A, Fryer A, Osborne JP, (1996) The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol 135: 1-5.
49. Schwartz RA, Fernandez G, Kotulska K, Jozwiak S, (2007) Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 57: 189-202.
50. Sun XF, Yan CL, Fang L, Shen FM, Liao KH, (2005) Cutaneous lesions and visceral involvement of tuberous sclerosis. Chin Med J (Engl) 118: 215-219.
51. Juvet SC, McCormack FX, Kwiatkowski DJ, Downey GP, (2007) Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans. Am J Respir Cell Mol Biol 36: 398-408.
52. Vanderhooft SL, Francis JS, Pagon RA, Smith LT, Sybert VP, (1996) Prevalence of hypopigmented macules in a healthy population. J Pediatr 129: 355-361.
53. Torrelo A, Hadj-Rabia S, Colmenero I, Piston R, Sybert VP, et al. (2012) Folliculocystic and collagen hamartoma of tuberous sclerosis complex. J Am Acad Dermatol 66: 617-621.
54. Aldrich CS, Hong CH, Groves L, Olsen C, Moss J, et al. (2009) Acral lesions in tuberous sclerosis complex: insights into pathogenesis. J Am Acad Dermatol 63: 244-251.
55. Zeller J, Friedmann D, Clerici T, Revuz J, (1995) The significance of a single periungual fibroma: report of seven cases. Arch Dermatol 131: 1465-1466.
56. Carlson RM, Lloyd KM, Campbell TE, (2007) Acquired periungual fibrokeratoma: a case report. Cutis 80: 137-140.
57. Cahn RL, (1977) Acquired periungual fibrokeratoma. A rare benign tumor previously described as the garlic-clove fibroma. Arch Dermatol 113: 1564-1568.
58. Jozwiak S, Kotulska K, Kasprzyk-Obara J, Domanska-Pakiela D, Tomyn-Drabik M, et al. (2006) Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics 118: e1146-1151.
59. Kotulska K, Larysz-Brysz M, Grajkowska W, Jozwiak J, Wlodarski P, et al. (2009) Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities. Pediatr Dev Pathol 12: 89-95.
60. Walker CL, Hunter D, Everitt JI, (2003) Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. Genes Chromosomes Cancer 38: 349-356.
61. Cui L, Ren Y, Yin H, Wang Y, Li D, et al. (2011) Increased expression of tuberin in human uterine leiomyoma. Fertil Steril 95: 1805-1808.
62. Luciano AA, (2009) Myomectomy. Clin Obstet Gynecol 52: 362-371.
63. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM, (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188: 100-107.
64. Lim GS, Oliva E, (2011) The morphologic spectrum of uterine PEC-cell associated tumors in a patient with tuberous sclerosis. Int J Gynecol Pathol 30: 121-128.
65. Piecha G, Chudek J, Wiecek A, (2008) Multiple Endocrine Neoplasia type 1. Eur J Intern Med 19: 99-103.
66. Perou ML, Gray PT, (1960) Mesenchymal hamartomas of the kidney. J Urol 83: 240-261.